GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » SEEGENE Inc (XKRX:096530) » Definitions » Operating Cash Flow per Share

SEEGENE (XKRX:096530) Operating Cash Flow per Share : ₩2,691.42 (TTM As of Mar. 2025)


View and export this data going back to 2010. Start your Free Trial

What is SEEGENE Operating Cash Flow per Share?

SEEGENE's operating cash flow per share for the three months ended in Mar. 2025 was ₩1,207.39. SEEGENE's operating cash flow per share for the trailing twelve months (TTM) ended in Mar. 2025 was ₩2,691.42.

During the past 12 months, the average Operating Cash Flow per Share Growth Rate of SEEGENE was 70.60% per year. During the past 3 years, the average Operating Cash Flow per Share Growth Rate was -34.00% per year. During the past 5 years, the average Operating Cash Flow per Share Growth Rate was 13.60% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the OCF Growth Rate using Operating Cash Flow per Share data.

The historical rank and industry rank for SEEGENE's Operating Cash Flow per Share or its related term are showing as below:

XKRX:096530' s 3-Year OCF Growth Rate Range Over the Past 10 Years
Min: -62.2   Med: 1.9   Max: 188.1
Current: -34

During the past 13 years, SEEGENE's highest 3-Year average Operating Cash Flow per Share Growth Rate was 188.10% per year. The lowest was -62.20% per year. And the median was 1.90% per year.

XKRX:096530's 3-Year OCF Growth Rate is ranked worse than
88.53% of 1221 companies
in the Biotechnology industry
Industry Median: 9.3 vs XKRX:096530: -34.00

SEEGENE Operating Cash Flow per Share Historical Data

The historical data trend for SEEGENE's Operating Cash Flow per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

SEEGENE Operating Cash Flow per Share Chart

SEEGENE Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Operating Cash Flow per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 3,685.27 6,448.85 6,280.69 1,986.57 1,851.69

SEEGENE Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Operating Cash Flow per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 362.83 434.84 920.80 128.40 1,207.39

Competitive Comparison of SEEGENE's Operating Cash Flow per Share

For the Biotechnology subindustry, SEEGENE's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


SEEGENE's Price-to-Operating-Cash-Flow Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, SEEGENE's Price-to-Operating-Cash-Flow distribution charts can be found below:

* The bar in red indicates where SEEGENE's Price-to-Operating-Cash-Flow falls into.


;
;

SEEGENE Operating Cash Flow per Share Calculation

Operating Cash Flow per Share is the amount of Cash Flow from Operations per outstanding share of the company's stock.

SEEGENE's Operating Cash Flow per Share for the fiscal year that ended in Dec. 2024 is calculated as

Operating Cash Flow per Share (A: Dec. 2024 )=Cash Flow from Operations (A: Dec. 2024 )/Shares Outstanding (Diluted Average) (A: Dec. 2024 )
=85390.805/46.115
=1,851.69

SEEGENE's Operating Cash Flow per Share for the quarter that ended in Dec. 2024 is calculated as

Operating Cash Flow per Share (Q: Mar. 2025 )=Cash Flow from Operations (Q: Mar. 2025 )/Shares Outstanding (Diluted Average) (Q: Mar. 2025 )
=55737.724/46.164
=1,207.39

Operating Cash Flow per Share for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩2,691.42

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


SEEGENE Operating Cash Flow per Share Related Terms

Thank you for viewing the detailed overview of SEEGENE's Operating Cash Flow per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


SEEGENE Business Description

Industry
Traded in Other Exchanges
N/A
Address
Taewon Building 65-5 Bangyi-Dong, Songpa-gu, Seoul, KOR, 138-050
SEEGENE Inc is engaged in the healthcare sector. The Korean firm specializes in developing upgraded technology for accurate diagnosis of various diseases. Its products include pathogen inspection solutions such as respiratory, gastrointestinal, tuberculosis and meningitis pathogens.

SEEGENE Headlines

No Headlines